Investment Thesis

. A price drop below $180 or significant negative earnings revisions could alter the attractiveness of the investment.

Competitive Moat

primarily through economies of scale and a well-established distribution network that generates significant switching costs for its customers. With a diverse product offering across both the Pharmaceutical and Medical segments, the company benefits from a high level of customer retention, as hospitals and healthcare providers rely heavily on consistent and reliable supply chains. However, competitive threats from emerging healthcare technology companies and other large distributors could challenge its market position over the next 5-10 years, necessitating ongoing innovation and adaptation.

Growth Engine

Future revenue growth for Cardinal Health is expected to materialize from increasing healthcare demand, particularly in the aging population demographic, and through strategic expansions into international markets. The total addressable market (TAM) for medical distribution is growing, with estimates suggesting a CAGR of approximately 7% over the next few years. The company is likely to gain market share organically, fueled by an expanding product portfolio and enhanced service offerings, particularly within specialty pharmaceuticals and medical supplies.